Rethinking the future of Medical Affairs

Adapt to the new pharmaceutical landscape focusing on innovation and cross-functional collaboration

16. Nov 2021

2 days course

English

12,300 DKK ex VAT
(app. 1,654 EUR ex VAT)
50% DISCOUNT FOR PUBLIC INSTITUTIONS

Summary

Do you have what it takes to be successful in Medical Affairs?

In the midst of rapid change, the Medical Affairs role faces multiple opportunities. The capability to generate relevant research and clinical data and provide meaningful interpretations to demonstrate patient value in real-life settings is in higher demand than ever.

As a result, new skills and competences are required of Medical Affairs professionals who – and at the same time Medical Affairs is invited to play a more strategic role.

Is your organisation geared towards the changes ahead? What are the future must-wins for Medical Affairs?

This course will strengthen your strategic thinking within Medical Affairs and thus enable you to contribute innovatively to the company´s success in today´s evolving life science environment.

Sign up now and bring a colleague: two participants for the price of one.

  

Hi! Do you need help choosing the right course?

We are ready to help you at +45 39 27 60 60 or contact@atriumcph.com

Key words

  • Medical Affairs
  • Data science
  • Real world evidence (RWE)
  • Medical impact
  • Medical Manager
Read more

Course leader(s) & Lecturers

  • Palle Torben Dahl
    Course leader
    Medical Affairs Specialist and TA Lead
    AstraZeneca A/S
  • Dr. Alexandra Zemp
    Lecturer
    Partner
    McKinsey, Zürich
  • Anders Borglykke
    Lecturer
    Director Advanced Analytics, Data Science
    Novo Nordisk A/S
  • Kreesten Meldgaard Madsen
    Lecturer
    Senior Director, Head of Medical Department
    LEO Pharma A/S
  • Ida Palsberg Hummelmose
    Lecturer
    Global Senior Market Access Manager
    LEO PHARMA A/S
  • Jens Gerwien
    Lecturer
    Senior Clinical Research Scientist, Immunology & Translational Medicines
    Eli Lilly Danmark A/S
  • Jens Quartarolo
    Lecturer
    Cluster Medical Director
    GSK Nordic
  • Karolina Rask
    Lecturer
    Director Clinical Operations
    Pfizer ApS
  • Klaus Kaae Andersen
    Lecturer
    Medical Evidence Scientific Lead, Real World Evidence, Oncology
    AstraZeneca A/S
  • Nicolai Fik
    Lecturer
    Market Access Director
    Bristol-Myers Squibb
  • Jesper Lindahl
    Lecturer
    Business Manager & Innovative lead
    Takeda Pharma A/S
  • Mikael Boesen
    Lecturer
    MD, Professor of Diagnostic Radiology
    Bispebjerg og Frederiksberg Hospital
  • Anupma Dhanda Farrington
    Lecturer
    Global Medical Director
    H. Lundbeck A/S
See all

IS THIS COURSE FOR YOU?

If you work in Medical Affairs either in a global or local function, this course will give you new perspectives on development opportunities within your area of expertise.


You will also benefit from attending the course if you consider pursuing a career in Medical Affairs or if you have a general interest in understanding how Medical Affairs will affect the development of life science in the future.

What you will learn

  1. Key deliverables and competences needed to master the Medical Affairs role in a global and affiliate perspective
  2. Understand key stakeholder expectations, internally as well as externally
  3. Understand the new, innovative role of the Medical Affairs function, and how it can work cross-functionally internally – and with high impact externally
  4. Improve your ability to prioritise Medical Affairs focus areas
  5. Build networks with colleagues in other Nordic pharma and biotech companies specifically addressing today´s needs for innovative thinking and clinically relevant projects

What your company will get

  1. An employee who is updated on today's principles of successful and innovative Medical Affairs deliverables
  2. An employee who is familiar with the competency needs of both global and local Medical Affairs functions
  3. Improved understanding of specific project types that may lead to improved patient outcomes in future projects

Course calendar

Starting 16. Nov 2021
16. Nov 2021 9:00-16:00

Day 1

  • Welcome and introduction
  • McKinsey on A vision for Medical Affairs in 2025
  • The role of Global Medical Affairs in driving future success, keynote lecture
  • Opportunities for Global Medical Affairs with Data Science, Clinical Development and Market Access
  • A deep dive into the new Global Medical & Scientific Affairs role
  • Group discussion on innovation in Global Medical Affairs
  • Wrap up/Q&A
17. Nov 2021 9:00-16:00

DAY 2

  • The role of affiliate Medical Affairs in driving future success, keynote lecture
  • Opportunities for affiliate Medical Affairs with Clinical Operations, Medical Evidence and Market Access
  • Business Development and innovation
  • Perspectives on public-private partnerships
  • Group discussion on innovation in affiliate Medical Affairs
  • Wrap up / Q&A
Practical information

Registration

Registration deadline
16. Nov 2021
Atrium
Lersø Parkallé 101
2100 København Ø
Sometimes things change. This is the expected programme.

Course information

Literature

Please download and read McKinsey’s whitepaper “A vision for

Medical Affairs in 2025”. You can find it here

Prerequisites

Basic understanding of pharmaceutical or biotech companies is recommended.

Examination

There is no examination in this course.

This course is a part of this programme

Pharma Consultant Programme

Design a medical training programme that fits your professional interests. Relevant if you work with or advice on drugs, maybe as a professional in sales and marketing, market access or public affairs in the pharma industry

Read more

Course leader(s)

Palle Torben Dahl
Medical Affairs Specialist and TA Lead
AstraZeneca A/S

Lecturers

Palle Torben Dahl
Medical Affairs Specialist and TA Lead
AstraZeneca A/S
Dr. Alexandra Zemp
Partner
McKinsey, Zürich
Anders Borglykke
Director Advanced Analytics, Data Science
Novo Nordisk A/S
Kreesten Meldgaard Madsen
Senior Director, Head of Medical Department
LEO Pharma A/S
Ida Palsberg Hummelmose
Global Senior Market Access Manager
LEO PHARMA A/S
Jens Gerwien
Senior Clinical Research Scientist, Immunology & Translational Medicines
Eli Lilly Danmark A/S
Jens Quartarolo
Cluster Medical Director
GSK Nordic
Karolina Rask
Director Clinical Operations
Pfizer ApS
Klaus Kaae Andersen
Medical Evidence Scientific Lead, Real World Evidence, Oncology
AstraZeneca A/S
Nicolai Fik
Market Access Director
Bristol-Myers Squibb
Jesper Lindahl
Business Manager & Innovative lead
Takeda Pharma A/S
Mikael Boesen
MD, Professor of Diagnostic Radiology
Bispebjerg og Frederiksberg Hospital
Anupma Dhanda Farrington
Global Medical Director
H. Lundbeck A/S

You may also be interested in these courses

Want to know more, or need help?

Contact Client Manager Christina Spangsberg at +45 39 15 09 22

Send me a message